Biopolym. Cell. 2018; 34(5):400-408.
Viruses and Cell
The molecular-genetic and phylogenetic analysis of the hemaglutinin gene from influenza viruses
- Educational and Scientific Center "Institute of Biology and Medicine",
Taras Shevchenko National University of Kyiv
64/13, Volodymyrska Str., Kyiv, Ukraine, 01601 - Gromashevsky L. V. Institute of Epidemiology and Infection Diseases, NAMS of Ukraine
5, Amosova Str., Kyiv, Ukraine, 03038
Abstract
Aim. To perform a phylogenetic and molecular-genetic analysis of the HA genes of influenza viruses that circulated in Ukraine during the 2016–2017 epidemic season, and to compare them with those that circulated in the world. Methods. Samples (nasopharyngeal swabs from patients) were analyzed using the real-time polymerase chain reaction (RT-PCR). Phylogenetic trees were constructed using MEGA 7 software. 3D structures were constructed in Chimera 1.11.2rc software. Results. Ukrainian isolates from the 2016–2017 season have substitutions in the antigenic sites which were not detected earlier; they and can influence the antigenic properties of viruses. Otherwise the A(H3N2) and B/Victoria viruses retained the similarity to the vaccine strains. For the A(H1N1)pdm09, a higher similarity to the vaccine strain recommended for the 2017–2018 epidemic season was observed. Conclusions. In the 2016–2017 epidemic season, all influenza viruses –A(H3N2), A(H1N1)pdm09 and B/Victoria acquired a number of unique amino-acid substitutions in the HA gene. The results of this study reaffirm the continuous genetic variability of circulating seasonal influenza viruses and the need for continued systematic antigenic and molecular surveillance.
Keywords: influenza viruses, hemagglutinin, antigenic site, mutation.
Full text: (PDF, in English)
References
[1]
ECDC working group on influenza A(H1N1)v. Preliminary analysis of influenza A(H1N1)v individual and aggregated case reports from EU and EFTA countries. Euro Surveill. 2009;14(23):19238.
[2]
Antón A, Pozo F, Niubó J, Casas I, Pumarola T. Influenza A(H1N1)pdm09 virus: viral characteristics and genetic evolution. Enferm Infecc Microbiol Clin. 2012;30 Suppl 4:10-7.
[3]
Igarashi M, Ito K, Yoshida R, Tomabechi D, Kida H, Takada A. Predicting the antigenic structure of the pandemic (H1N1) 2009 influenza virus hemagglutinin. PLoS One. 2010;5(1):e8553.
[4]
Ann J, Papenburg J, Bouhy X, Rhéaume C, Hamelin MÈ, Boivin G. Molecular and antigenic evolution of human influenza A/H3N2 viruses in Quebec, Canada, 2009-2011. J Clin Virol. 2012;53(1):88-92.
[5]
Korsun N, Angelova S, Gregory V, Daniels R, Georgieva I, McCauley J. Antigenic and genetic characterization of influenza viruses circulating in Bulgaria during the 2015/2016 season. Infect Genet Evol. 2017;49:241-250.
[6]
Kumar S, Stecher G, Tamura K. MEGA7: Molecular Evolutionary Genetics Analysis Version 7.0 for Bigger Datasets. Mol Biol Evol. 2016;33(7):1870-4.
[7]
Mironenko AP, Holubka OS, Smutro OY, Radchenko LV, Fesenko AY. The Results of the Influenza Epidemic Season in Ukraine in 2016-2017 and forecast for the next season 2017-2018. Klin Immunol Allergol Infectol. 2017; 5(102):5-8.
[8]
Lee HK, Tang JW, Kong DH, Loh TP, Chiang DK, Lam TT, Koay ES. Comparison of mutation patterns in full-genome A/H3N2 influenza sequences obtained directly from clinical samples and the same samples after a single MDCK passage. PLoS One. 2013;8(11):e79252.
[9]
World Health Organization. Recommended composition of influenza virus vaccines for use in the 2016 southern hemisphere influenza season. Weekly Epidemiological Record. 2015; 90,(41):545-60.
[10]
Koel BF, Mögling R, Chutinimitkul S, Fraaij PL, Burke DF, van der Vliet S, de Wit E, Bestebroer TM, Rimmelzwaan GF, Osterhaus AD, Smith DJ, Fouchier RA, de Graaf M. Identification of amino acid substitutions supporting antigenic change of influenza A(H1N1)pdm09 viruses. J Virol. 2015;89(7):3763-75.
[11]
Ramadhany R, Yasugi M, Nakamura S, Daidoji T, Watanabe Y, Takahashi K, Ikuta K, Nakaya T. Tropism of Pandemic 2009 H1N1 Influenza a Virus. Front Microbiol. 2012;3:128.